South & Central America Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Cli

South & Central America Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Clinics, and Others)

The South & Central America parenteral nutrition market was valued at US$ 360.63 million in 2022 and is expected to reach US$ 597.42 million by 2030; it is estimated to record a CAGR of 6.5% from 2022 to 2030.

Improved Healthcare Infrastructure Fuels South & Central America Parenteral Nutrition Market

With over 19,000 hospitals in the region, Latin America provides a wide range of healthcare options. As of 2023, there will be 6,642 more hospitals in Brazil than there are in the US. Investments in healthcare infrastructure and the expansion of healthcare facilities in the South & Central America region present opportunities for the development and distribution of parenteral nutrition products and services.

Additionally, malnutrition affects 74% of severely ill hospitalized patients in Latin America. In order to fight patient malnutrition in Latin America and around the world, Fresenius Kabi is dedicated to advancing research and providing funds. Under the 'United for Clinical Nutrition' project, which aims to strengthen clinical research in Latin America, the company has provided research grants totaling US$ 106,630 (100,000) since 2018.

In 2023, Healthcare practitioners applied for the third Parenteral Nutrition Research Grant Latin America to fund clinical nutrition research initiatives. The award is valid for two years. It seeks to support serious research in parenteral nutrition therapy, help solve the problem of malnourished critically ill patients in Latin America and provide funds to support additional research that will support appropriate parenteral nutrition.

South & Central America Parenteral Nutrition Market Overview

The incidence of neurological disorders has been correlated with the aging population in Brazil. According to the World Health Organization and the Brazilian Institute of Geography and Statistics, by 2040, the geriatric population in Brazil (aged above 60 years) will reach ~55 million. In the coming years, the rising geriatric population is anticipated to increase the incidence of chronic neurological disorders, which is likely to propel the demand for parenteral nutrition. Thus, the growing incidence of diabetes, cancer, and other chronic diseases drives the parenteral nutrition market in Brazil. This factor is likely to increase the demand for parenteral nutrition in treating patients.

South & Central America Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Parenteral Nutrition Market Segmentation

The South & Central America parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the South & Central America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the South & Central America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America parenteral nutrition market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the South & Central America parenteral nutrition market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America parenteral nutrition market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America parenteral nutrition market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.